Skip to main content

Profiles

Merck

Merck & Co., Inc., known outside North America as MSD,[1] is an American multinational pharmaceutical company based in Kenilworth, New Jersey.[2]

History

In May 2002, The Bill & Melinda Gates Foundation purchased stock in Merck.[3]

On August 5, 2010, Merck and the Gates Foundation announced a joint five-year $60 million contribution to the African Comprehensive HIV/AIDS Partnerships for efforts related to HIV/AIDS and tuberculosis in Botswana.[4]

On June 29, 2016, Merck and Moderna announced they were collaborating on the development of mRNA-based cancer vaccines, including work with Merck's Keytruda, an antibody-based immunotherapy drug.[5]

COVID-19

Near the end of March 2020, Merck joined the COVID-19 Therapeutics Accelerator alongside a "consortium of life sciences companies."[6]

In January 2021, MyID announced a partnership with Merck to "provide the MyID mobile app and wristband to patients" being treated with Merck's Keytruda.[7]

Merck participated as a partner in the This Is Our Shot campaign to mass advertise COVID-19 vaccines, which launched April 28, 2021.[8][9]

Merck collaborated with Ridgeback Biotherapeutics to develop molnupiravir, an oral mutagenic anti-viral compound, to treat COVID-19. In October 2021, the two companies reported that data from their Phase 3 clinical trial showed molnupiravir “cuts the risk of hospitalization and death from COVID-19 by 50% in people who have mild to moderate forms of the disease.”[10][11]

Merck was a sponsor for the National Community Pharmacists Association 2021 Annual Convention from October 9-12, 2021.[12]

On November 30, 2021, the Food and Drug Administration (FDA)'s Antimicrobial Drugs Advisory Committee narrowly recommended the use of molnupiravir in a 13-10 vote.[13]

On December 3, 2021, Merck announced it had entered an agreement with the Government of Canada to supply the country with up to one million "patient courses" of molnupiravir.[14]

In January 2022, Merck and Ridgeback announced they would supply UNICEF with 3 million doses of molnupiravir through the Access to COVID-19 Tools Accelerator (ACT-Accelerator) Therapeutics Partnership.[15]

Organization

Name Position Notes
William Daley Board Member[16] JPMorgan Chase, Third Way, Boeing, Council on Foreign Relations
Julie Gerberding Chief Patient Officer and Executive Vice President of Population Health and Sustainability (former)[1:1] The Commons Project, Centers for Disease Control and Prevention (CDC)
Richard Henriques Senior Vice President of Finance for Global Human Health; Vice President and Corporate Controller; Principal Accounting Officer (all former)[17] Arbutus Biopharma, University of Pennsylvania, EMulate Therapeutics, Cabaletta Bio, Franklin Institute, Heritage Conservancy, Episcopal Community Services, Bill & Melinda Gates Foundation
Fernando Pons Regional Director Project Realization (former)[18] Coalition for Epidemic Preparedness Innovations (CEPI), ED&F Man, European Bank for Reconstruction and Development (EBRD), ExxonMobil, Rio Tinto
Walter Strapps Director of RNAi Therapeutics (former)[19] Deep Genomics, Liberate Bio, Carver Biosciences, Gemini Therapeutics, Intellia Therapeutics, Sirna Therapeutics, Sentigen Biosciences, Sona Nanotech
Princess Therese of Liechtenstein Strategic Projects Manager (former)[20] Geopolitical Intelligence Services (GIS), M Ventures

Subsidiaries

  • EMD Serono
  • M Ventures
  • Merck Foundation
  • Merck Global Health Innovation Fund
  • Partnership for Giving (P4G)

Partners

Merck is partnered with or a member of:

Merck has been a tenant at MaRS Discovery District.[33] The company has received funding from the Bill & Melinda Gates Foundation Strategic Investment Fund.[34]

Activities

Merck has provided notable funding to:

  1. Moody, M., & Herrmann, J. (2022, March 1). Dr. Julie L. Gerberding to Retire from Merck. Merck. https://web.archive.org/web/20240706000359/https://www.merck.com/news/dr-julie-l-gerberding-to-retire-from-merck/ ↩︎ ↩︎

  2. The Trusted Provider of Medical Information since 1899. Merck Manuals. Retrieved January 18, 2022, from https://archive.ph/nYPYj ↩︎

  3. Bank, D., & Buckman, R. (2002, May 17). Gates Foundation buys stakes in drug makers. Wall Street Journal. https://archive.ph/XP9QA ↩︎

  4. Merck, Gates Foundation Give $60 Million to Fight HIV/AIDS in Botswana. (2010, August 25). Philanthropy News Digest; Candid. http://archive.today/2023.06.21-180752/https://philanthropynewsdigest.org/news/merck-gates-foundation-give-60-million-to-fight-hiv-aids-in-botswana ↩︎

  5. Eisele, P., & Ronaldo, C. (2016, June 29). Merck and Moderna Announce Strategic Collaboration to Advance Novel mRNA-Based Personalized Cancer Vaccines with KEYTRUDA® (pembrolizumab) for the Treatment of Multiple Types of Cancer. Moderna. https://web.archive.org/web/20170405190328/https://www.modernatx.com/newsroom/press-releases/merck-and-moderna-announce-strategic-collaboration-advance-novel-mrna-based ↩︎

  6. Staines, R. (2020, March 26). Pharma giants including Novartis collaborate on COVID-19 therapies. Pharmaphorum. http://archive.today/2022.01.18-165943/https://pharmaphorum.com/news/collaborate-covid19-therapies/ ↩︎ ↩︎

  7. MyID launches partnership with Merck & Co Inc. for KEYTRUDA. (2021, January 20). St George News. http://archive.today/2023.07.18-183154/https://www.stgeorgeutah.com/news/archive/announcements/myid-launches-partnership-with-merck-co-inc-for-keytruda/ ↩︎

  8. Home. This Is Our Shot Canada. Retrieved July 14, 2023, from https://web.archive.org/web/20230714200256/https://thisisourshot.ca/ ↩︎

  9. “This is Our Shot” Rallies Canadians to Get Vaccinated Against COVID-19. (2021, April 28). This Is Our Shot Canada. https://web.archive.org/web/20230714200244/https://thisisourshot.ca/this-is-our-shot-rallies-canadians-to-get-vaccinated-against-covid-19/ ↩︎

  10. Moody, M., Ryan, P., Dannenbaum, P., Kruper, R., & Carvalho, C. (2021, October 1). Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study. Merck. Retrieved December 5, 2021, from https://archive.ph/Ov4Cg ↩︎

  11. Halford, B., Howes, L., & Satyanarayana, M. (2021, October 1). Molnupiravir reduces risk of hospitalization and death in patients with mild to moderate COVID-19. Chemical & Engineering News; American Chemical Society. https://archive.ph/8sJfE ↩︎

  12. Annual Convention. National Community Pharmacists Association. Retrieved October 2, 2021, from https://web.archive.org/web/20211002000616/https://ncpa.org/annual-convention ↩︎

  13. Lee, J. (2021, November 30). FDA advisers recommend Merck’s COVID-19 pill in close vote. MarketWatch. https://ghostarchive.org/archive/X40X1 ↩︎

  14. Kilgore, T. (2021, December 3). Merck to supply Government of Canada with up to 1 million courses molnupiravir, its COVID-19 pill. MarketWatch. Retrieved December 5, 2021, from http://archive.today/2021.12.06-015701/https://www.marketwatch.com/story/merck-to-supply-government-of-canada-with-up-to-1-million-courses-molnupiravir-its-covid-19-pill-2021-12-03 ↩︎

  15. Moody, M. (2022, January 18). Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine. Merck. https://archive.ph/gpZRy ↩︎

  16. William M. Daley Named Chairman Of The Midwest Of JPMorgan Chase. (2004, May 17). JPMorgan Chase. https://web.archive.org/web/20240706004914/https://jpmorganchaseco.gcs-web.com/news-releases/news-release-details/william-m-daley-named-chairman-midwest-jpmorgan-chase ↩︎

  17. Richard C. Henriques. Arbutus BioPharma. Retrieved September 26, 2021, from https://web.archive.org/web/20210926102848/https://investor.arbutusbio.com/board-directors/richard-c-henriques ↩︎

  18. Fernando Pons. European Bank for Reconstruction and Development. Retrieved July 6, 2024, from https://web.archive.org/web/20240706000029/https://www.ebrd.com/executive-committee/fernando-pons.html ↩︎

  19. Walter Strapps: Positions, Relations and Network. MarketScreener. Retrieved July 6, 2024, from https://web.archive.org/web/20240706030556/https://uk.marketscreener.com/insider/WALTER-STRAPPS-A37E7P/ ↩︎

  20. GIS Expert Princess Therese of Liechtenstein. (2022, January 26). Geopolitical Intelligence Services. https://web.archive.org/web/20240407012448/https://www.gisreportsonline.com/e/liechtenstein-therese-of/ ↩︎

  21. Current Organizational Members. AcademyHealth. Retrieved May 8, 2022, from https://archive.ph/CjV83 ↩︎

  22. ACTIV. National Institutes of Health (NIH). Retrieved April 1, 2022, from http://archive.today/2022.01.11-042823/https://www.nih.gov/research-training/medical-research-initiatives/activ ↩︎

  23. Member Logos. Ad Standards. Retrieved September 17, 2021, from https://web.archive.org/web/20210917052119/https://adstandards.ca/about/membership/member-logos/ ↩︎

  24. AVAC Member Organizations. (2021). Adult Vaccine Access Coalition. http://archive.today/2022.07.08-060340/https://adultvaccinesnow.org/our-membership/avac-member-organizations/ ↩︎

  25. List of Members. (2022, March 4). Alliance for a Stronger FDA. http://archive.today/2022.07.08-045902/https://www.strengthenfda.org/members ↩︎

  26. BIO Member Directory. Biotechnology Innovation Organization. Retrieved September 30, 2022, from https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory ↩︎

  27. Partners. CIHR Canadian HIV Trials Network. Retrieved February 2, 2023, from https://web.archive.org/web/20230202063247/https://www.hivnet.ubc.ca/partners/ ↩︎

  28. Meet Our Partners. Concordia. Retrieved February 14, 2024, from http://archive.today/2024.02.14-062904/https://www.concordia.net/meet-our-partners/ ↩︎

  29. Members & Governance. World Federation of Advertisers. Retrieved December 2, 2023, from https://web.archive.org/web/20231202141727/https://wfanet.org/leadership/garm/members-governance ↩︎

  30. Current Members. MCDC. Retrieved January 3, 2023, from http://archive.today/2023.01.03-195328/https://www.medcbrn.org/current-members/ ↩︎

  31. About. PhRMA. Retrieved September 14, 2023, from https://web.archive.org/web/20230914221250/https://phrma.org/About ↩︎

  32. Merck. World Economic Forum. Retrieved February 10, 2022, from https://archive.ph/a7J76 ↩︎

  33. Treurnicht, I., & Nixon, G. (2014, December 9). 2012 MaRS Annual Report. Issuu; MaRS. https://issuu.com/derekaubichon/docs/mar-anr6786_2012_annual_report_elec/1 ↩︎

  34. Portfolio - Page 2. Bill & Melinda Gates Foundation Strategic Innovation Fund. Retrieved September 27, 2023, from https://web.archive.org/web/20230927091305/https://sif.gatesfoundation.org/portfolio/?fwp_paged=2&fwp_per_page=30 ↩︎

  35. Who we are. (2021, May 12). 19 to Zero. https://web.archive.org/web/20210512021256/https://www.19tozero.ca/who-we-are ↩︎

  36. How We’re Funded. (2022). Alliance for Aging Research. https://web.archive.org/web/20220715161317/https://www.agingresearch.org/about-us/how-were-funded/ ↩︎

  37. Annual Disaster Giving Program (ADGP) and Disaster Responder Program. American Red Cross. Retrieved November 15, 2022, from http://archive.today/2022.11.15-233416/https://www.redcross.org/donations/companies-and-foundations/adgp-disaster-responder-program.html↩︎ ↩︎

  38. Our Public Health Heroes. BCCDC Foundation for Public Health. Retrieved July 25, 2021, from https://web.archive.org/web/20210725052518/https://bccdcfoundation.org/our-donors/ ↩︎

  39. Final Release Package A-2023-00059 CBC, Advertising Companies. CBC/Radio-Canada. Retrieved October 1, 2023, from https://archive.org/details/final-release-package-a-2023-00059-cbc-advertising-companies ↩︎

  40. Pekeles, G. S. Outfront: Annual Report 2007-2008. Canadian Paediatric Society. Retrieved June 26, 2023, from https://web.archive.org/web/20230604214219/https://cps.ca/uploads/publications/AnnualReport07-08-1.pdf ↩︎ ↩︎

  41. Lenzer, J. (2015). Centers for Disease Control and Prevention: protecting the private good? BMJ, 350(may15 3), h2362–h2362. https://doi.org/10.1136/bmj.h2362 ↩︎

  42. Supporters of the COVID-19 Solidarity Response Fund for WHO. (2020, May 26). WHO Foundation. https://web.archive.org/web/20200526183201/https://covid19responsefund.org/en/supporters ↩︎

  43. Turque, B. (2000, August 20). The Soul And The Steel. Newsweek. http://archive.today/2020.08.06-155924/https://www.newsweek.com/soul-and-steel-158731 ↩︎

  44. Who We Are. Global Liver Institute. Retrieved July 10, 2023, from https://web.archive.org/web/20230710042334/https://globalliver.org/who-we-are/ ↩︎

  45. Leading the Way to 2030: 2018 Annual Report. Hepatitis B Foundation. Retrieved March 14, 2023, from https://web.archive.org/web/20230314121320/https://www.hepb.org/assets/Uploads/HepB-2018-Annual-Report-FINAL.pdf ↩︎

  46. Stern, W. P., & London, H. I. (2003, January 1). 2002 Hudson Institute Annual Report. Hudson Institute. https://web.archive.org/web/20130923185459/http://www.hudson.org/files/publications/Hudson2002AnnualReportFinal.pdf ↩︎

  47. Peter Andrew McCullough. Open Payments Data - CMS. Retrieved February 2, 2024, from https://openpaymentsdata.cms.gov/physician/335114 ↩︎

  48. Plump, A., & Miller, A. M. (2022, June). 2021 Annual Report. PhRMA Foundation. https://web.archive.org/web/20230219205032/https://www.phrmafoundation.org/wp-content/uploads/2022/06/PhRMAFoundation_2021AnnualReport.pdf ↩︎

  49. Merck & Co. OpenSecrets. Retrieved July 5, 2024, from https://www.opensecrets.org/orgs/merck-co/recipients?id=D000000275 ↩︎

  50. More of Our Partners. United Nations Foundation. Retrieved October 1, 2023, from https://web.archive.org/web/20231001222831/https://unfoundation.org/who-we-are/our-partners/more-of-our-partners-2/ ↩︎

  51. Voluntary contributions by fund and by contributor, 2021. (2022). World Health Organization. https://web.archive.org/web/20220516042059/https://apps.who.int/gb/ebwha/pdf_files/WHA75/A75_INF5-en.pdf ↩︎

  52. Dasgupta, A. (2022). From Commitments to Action: Annual Report 2021 (pp. 38–47). World Resources Institute. https://web.archive.org/web/20220730190344/https://files.wri.org/d8/s3fs-public/2022-04/wri-annual-report-2021.pdf ↩︎